13G Filing: Armistice Capital and Aytu Bioscience Inc (AYTU)

Page 11 of 11

Page 11 of 11 – SEC Filing

Exhibit A

AGREEMENT

The undersigned agree that this Schedule
13G dated August 24, 2017 relating to the Common Stock, par value $0.0001, of Aytu Bioscience, Inc. shall be filed on behalf of
the undersigned.

Armistice Capital, LLC

By: /s/ Steven Boyd

__________________________

Steven Boyd

Managing Member

Armistice Capital Master Fund Ltd.

By: /s/ Steven Boyd

__________________________

Steven Boyd

Director

/s/ Steven Boyd

__________________________

Steven Boyd

Follow Aytu Biopharma Inc (NASDAQ:AYTU)

Page 11 of 11